Therapeutical Class：Penicillinase-resistant penicillins, inhibit cell wall synthesis by inhibiting the final transpeptidation step of peptidoglycan synthesis

Indication：Penicillinase-producing Staphylococci, β-hemolytic Streptococci, S. pneumoniae.

Administraton：PO.

Adults: 125-1000 mg q6h.

Erysipelas, otitis externa, skin abscess: 500 mg q6h.

MSSA infection: 500-1000 mg q6-8h.

Children: < 40 kg: 12.5-100 mg/kg/day q6h.

> 40 kg: 125-250 mg q6h.

Adverse Effect：Diarrhea, nausea, vomiting, hepatitis, epigastric or abdominal pain, pruritus, rash.

Pregnancy Risk：BSupply：Diclocin XE “Diclocin”  250mg Cap (德可信膠囊) ＜10073＞